Soft Tissue Sarcoma: The Predominant Primary Malignancy in the Retroperitoneum

Autor: Thijs van Dalen, Jan-Willem W. Coebergh, Mariel K. Casparie, Charles H. F. Gimbrère, Harald J. Hoekstra, Bert N. Van Geel, Frits Van Coevorden, Adriaan Hennipman

Publikováno v: Sarcoma, Vol 5, Iss 1, Pp 5-8 (2001)

Purpose. In the clinical work-up of a retroperitoneal mass, the diagnosis of soft tissue sarcoma is often not considered. Incidence rates of various malignant and benign retroperitoneal tumours were studied to determine the incidence of soft tissue s

Externí odkaz: https://doaj.org/article/0281e0baea3d44b493740dbbe928503f

Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma

Autor: Piet Slootweg, Murray F. Brennan, Samuel Singer, A. Hennipman, Bert N. van Geel, Frits van Coevorden, Harald J. Hoekstra, Cherry F. Albus Lutter, Thijs van Dalen

Publikováno v: Annals of Surgical Oncology, 11(5), 483-490. Springer New York
Annals of Surgical Oncology, 11, 5, pp. 483-90
Annals of Surgical Oncology, 11(5), 483-490. SPRINGER
Annals of Surgical Oncology, 11, 483-90

Item does not contain fulltext BACKGROUND: The present AJCC/TNM staging system is of limited value for prediction of prognosis for patients with retroperitoneal sarcoma. The objective of the present study was to develop a postsurgical classification

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d50e02a9469f5506e8d02a88652395d5
https://hdl.handle.net/2066/58533

Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma

Autor: Guus Hart, Alexander M.M. Eggermont, Joost M. Klaase, Bin B. R. Kroon, Bart C. Vrouenraets, Omgo E. Nieweg, Bert N. van Geel

Publikováno v: Journal of the American College of Surgeons, 188(5), 522-530. Elsevier Inc.

Background: The optimal toxic reaction of the normal tissues in perfused limbs after isolated limb perfusion (ILP) is unknown. Theoretically, more severe limb toxicity could reflect a concomitant increased toxic effect to the tumor and improved outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d769d828d94ca9c9d54e7ddd5c25f3b2
https://doi.org/10.1016/s1072-7515(99)00018-6

Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb

Autor: H. R. Franklin, Bin B. R. Kroon, Joost M. Klaase, Bert N. van Geel, Joop A. van Dongen, Alexander M.M. Eggermont

Publikováno v: European Journal of Cancer. 29:325-328

From 1985 to 1990 43 patients with measurable locally inoperable or recurrent melanoma of the lower limb were treated according to a double perfusion schedule. The dose of melphalan given in the first perfusion was low (6 mg/l; 1 h; normothermic) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7771c6129782ab22a9a942664e3b5b20
https://doi.org/10.1016/0959-8049(93)90377-r

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation

Autor: Curt W. Burger, Ans W.M. van den Ouweland, Caroline Seynaeve, Jan G. M. Klijn, Hanne Meijers-Heijboer, Astrid Baalbergen, Ellen Crepin, Cecile T. M. Brekelmans, Marian B. E. Menke-Pluymers, Bert N. van Geel

Publikováno v: Journal of Clinical Oncology, 21(9), 1675-1681. American Society of Clinical Oncology
Journal of clinical oncology, 21(9), 1675-1681. American Society of Clinical Oncology

Purpose: To analyze the use of genetic testing, prophylactic mastectomy, and oophorectomy among women with breast and/or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Patients and Methods: We examined prospectively the use of BRCA1/BRC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54d2b3f0b0b48de221e89e322fe79471
https://pubmed.ncbi.nlm.nih.gov/12721241